DBV Technologies (DBVT) Operating Leases (2019 - 2026)
DBV Technologies (DBVT) reported Operating Leases of $6.1 million for Q1 2026, down 15.68% year-over-year from $7.2 million in Q1 2025, and down 6.15% on a QoQ basis from $6.5 million in Q4 2025.
DBV Technologies (DBVT) has 8 years of Operating Leases data on file, last reported at $6.1 million in Q1 2026.
- Quarterly Operating Leases fell 15.68% year-over-year to $6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.1 million (down 15.68% YoY) and the FY2025 annual result came in at $6.5 million, up 3.22% from the prior year.
- Operating Leases declined to $6.1 million in Q1 2026 per DBVT's latest filing, from $6.5 million in the prior quarter.
- Across five years, Operating Leases topped out at $7.4 million in Q3 2024 and bottomed at $94000.0 in Q3 2023.
- The 5-year median for Operating Leases is $6.1 million (2026), against an average of $4.7 million.
- The widest annual swing landed in 2023, when Operating Leases sank 96.65%; it then jumped 7785.11% in 2024.
- Tracing DBVT's Operating Leases over 5 years: stood at $1.1 million in 2022, then soared by 403.02% to $5.7 million in 2023, then increased by 11.08% to $6.3 million in 2024, then grew by 3.22% to $6.5 million in 2025, then declined by 6.15% to $6.1 million in 2026.
- Per Business Quant, the three latest DBVT Operating Leases figures stand at $6.1 million (Q1 2026), $6.5 million (Q4 2025), and $6.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.10 Mn |
| Dec 31, 2025 | 6.50 Mn |
| Sep 30, 2025 | 6.69 Mn |
| Jun 30, 2025 | 6.70 Mn |
| Mar 31, 2025 | 7.23 Mn |
| Dec 31, 2024 | 6.30 Mn |
| Sep 30, 2024 | 7.41 Mn |
| Jun 30, 2024 | 6.78 Mn |
| Mar 31, 2024 | 7.03 Mn |
| Dec 31, 2023 | 5.67 Mn |
| Sep 30, 2023 | 94,000.00 |
| Jun 30, 2023 | 2.13 Mn |
| Mar 31, 2023 | 680,000.00 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 2.80 Mn |
| Jun 30, 2022 | 1.95 Mn |
| Mar 31, 2022 | 4.30 Mn |
| Dec 31, 2021 | 10.15 Mn |
| Sep 30, 2021 | 8.30 Mn |
| Jun 30, 2021 | 9.16 Mn |
| Mar 31, 2021 | 9.53 Mn |
| Dec 31, 2020 | 10.50 Mn |
| Dec 31, 2019 | 25.30 Mn |